Comparative Effectiveness of Paclitaxel-Based Femoropopliteal Interventions

Rogers JH Laird JR . Overview of new technologies for lower extremity revascularization. Circulation. 2007;116:2072–2085.

Laird JR Katzen BT Scheinert D . Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1–9.

Zeller T Krankenberg H Steinkamp H . One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009;16:653–662.

Zeller T Rastan A Sixt S . Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol. 2006;48:1573–1578.

Laird JR Zeller T Gray BH . Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13:1–11.

Zeller T Schmidt A Rastan A . Initial experience with the 5×300-mm Proteus Embolic Capture Angioplasty Balloon in the treatment of peripheral vascular disease. J Endovasc Ther. 2012;19:826–833.

Armstrong EJ Saeed H Alvandi B . Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions. J Endovasc Ther. 2014;21:34–43.

Tepe G Zeller T Albrecht T . Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689–699.

Werk M Langner S Reinkensmeier B . Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358–1365.

Werk MM Albrecht TT Meyer D . Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831–840.

Micari A Cioppa A Vadalà G . Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv. 2012;5:331–338.

Micari A Cioppa A Vadalà G . 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry. JACC Cardiovasc Interv. 2013;6:282–289.

Scheinert D Duda S Zeller T . The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7:10–19.

Dake MD Ansel GM Jaff MR . Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495–504.

Dake MD Scheinert D Tepe G .; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613–623.

Bosiers MM Peeters PP Tessarek JJ . The Zilver PTX single arm study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg (Torino). 2013;54:115–122.

Dake MD Ansel GM Jaff MR . Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61:2417–2427.

Zeller T Rastan A Macharzina R . Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014;21:359–368.

Cioppa A Stabile E Popusoi G . Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med. 2012;13:219–223.

Gandini R Del Giudice C Merolla S . Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther. 2013;20:805–814.